The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for glaucoma than the use of non-CGRP inhibitors, a new study shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/cgrp-inhibitors-migraine-linked-reduced-glaucoma-risk-2026a1000eu7?src=rss
Author :
Publish date : 2026-05-08 10:51:00
Copyright for syndicated content belongs to the linked Source.
